Updated Date: Wed, 09 Feb 2022 00:00:00 EST

Saphnelo is the first therapy in over a decade for patients with moderate to severe systemic lupus erythematosus

Rare Disease Day has inspired a pioneering video to support patients living with rare conditions

Scientists have developed mathematical models that act as patient ‘surrogates’ for evaluating potential prostate cancer treatments.

A new study adds to a growing body of evidence that organoids — lab-grown collections of cells that […]

Lilly’s tirzepatide doesn’t necessarily top diabetes rivals Jardiance and Ozempic, ICER says fkansteiner Wed, 02/16/2022 – 11:57

3 more deaths among patients on Biogen’s Aduhelm fuel safety concerns, though no link established: analyst kdunleavy Wed, […]

A reduced risk of infection and, as a consequence, a decrease in new infections are goals that have […]

An interim analysis of an ongoing Phase III study from UCLA Jonsson Comprehensive Cancer Center indicates that using […]

Grace (not her real name) is a primary school teacher in Malawi.1 She was also a university student, […]